SGOL2 is a novel prognostic marker and fosters disease progression via a MAD2-mediated pathway in hepatocellular carcinoma

Overview of attention for article published in Biomarker Research, November 2022

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age

Mentioned by

twitter: 2 X users

Citations

dimensions_citation: 6 Dimensions

Readers on

mendeley: 2 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 2,311 followers.

We've detected a paper from Biomarker Research that cites a retracted paper post-retraction. Citing paper: https://t.co/YksMN7DmSU Retracted paper: https://t.co/spCrvohRhN

22 Dec 2022

Reply Repost Favourite

SGOL2 is a novel prognostic marker and fosters disease progression via a MAD2-mediated pathway in hepatocellular carcinoma | Qingqing Hu | https://t.co/A2rydOEqHD

16 Nov 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.